Clinical Trials Browser

Phase 2 × Glioma × nimotuzumab × Clear all

NCT03388372 2018-01-03

Nimotuzumab Plus Radiotherapy With Concomitant and Adjuvant Temozolomide for Cerebral Glioblastoma

Phase 2 Completed

Glioblastoma, Glioma